GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (NYSE:ELAN) » Definitions » Piotroski F-Score

Elanco Animal Health (Elanco Animal Health) Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 2018. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elanco Animal Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Elanco Animal Health's Piotroski F-Score or its related term are showing as below:

ELAN' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 6
Current: 4

During the past 9 years, the highest Piotroski F-Score of Elanco Animal Health was 6. The lowest was 2. And the median was 5.


Elanco Animal Health Piotroski F-Score Historical Data

The historical data trend for Elanco Animal Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 2.00 6.00 5.00 4.00

Elanco Animal Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 6.00 5.00 4.00

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanco Animal Health Piotroski F-Score Distribution

For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Elanco Animal Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 103 + -97 + -1096 + -141 = $-1,231 Mil.
Cash Flow from Operations was -145 + 61 + 198 + 157 = $271 Mil.
Revenue was 1257 + 1057 + 1068 + 1035 = $4,417 Mil.
Gross Profit was 763 + 623 + 581 + 519 = $2,486 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(15491 + 15769 + 15796 + 14344 + 14362) / 5 = $15152.4 Mil.
Total Assets at the begining of this year (Dec22) was $15,491 Mil.
Long-Term Debt & Capital Lease Obligation was $5,736 Mil.
Total Current Assets was $3,407 Mil.
Total Current Liabilities was $1,241 Mil.
Net Income was 51 + -10 + -65 + -54 = $-78 Mil.

Revenue was 1226 + 1175 + 1026 + 985 = $4,412 Mil.
Gross Profit was 717 + 691 + 554 + 537 = $2,499 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(16478 + 16251 + 15601 + 14948 + 15491) / 5 = $15753.8 Mil.
Total Assets at the begining of last year (Dec21) was $16,478 Mil.
Long-Term Debt & Capital Lease Obligation was $5,448 Mil.
Total Current Assets was $3,279 Mil.
Total Current Liabilities was $1,702 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elanco Animal Health's current Net Income (TTM) was -1,231. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Elanco Animal Health's current Cash Flow from Operations (TTM) was 271. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-1231/15491
=-0.0794655

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-78/16478
=-0.00473358

Elanco Animal Health's return on assets of this year was -0.0794655. Elanco Animal Health's return on assets of last year was -0.00473358. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Elanco Animal Health's current Net Income (TTM) was -1,231. Elanco Animal Health's current Cash Flow from Operations (TTM) was 271. ==> 271 > -1,231 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=5736/15152.4
=0.37855389

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=5448/15753.8
=0.34582133

Elanco Animal Health's gearing of this year was 0.37855389. Elanco Animal Health's gearing of last year was 0.34582133. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=3407/1241
=2.74536664

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=3279/1702
=1.92655699

Elanco Animal Health's current ratio of this year was 2.74536664. Elanco Animal Health's current ratio of last year was 1.92655699. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Elanco Animal Health's number of shares in issue this year was 492.9. Elanco Animal Health's number of shares in issue last year was 488.3. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2486/4417
=0.56282545

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2499/4412
=0.56640979

Elanco Animal Health's gross margin of this year was 0.56282545. Elanco Animal Health's gross margin of last year was 0.56640979. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=4417/15491
=0.2851333

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=4412/16478
=0.26775094

Elanco Animal Health's asset turnover of this year was 0.2851333. Elanco Animal Health's asset turnover of last year was 0.26775094. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+1+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Elanco Animal Health has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Elanco Animal Health  (NYSE:ELAN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Elanco Animal Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Elanco Animal Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanco Animal Health (Elanco Animal Health) Business Description

Traded in Other Exchanges
Address
2500 Innovation Way, Greenfield, IN, USA, 46140
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Executives
Grace Mcardle officer: EVP, MANUFACTURING AND QUALITY 2500 INNOVATION WAY, GREENFIELD IN 46140
Timothy J Bettington officer: See remarks C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
R David Hoover director C/O EDGEWELL PERSONAL CARE COMPANY, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Jeffrey N Simmons director, officer: Pres., Chief Executive Officer 2500 INNOVATION WAY, GREENFIELD IN 46140
John P Bilbrey director
Rajeev A. Modi officer: See Remarks 2500 INNOVATION WAY, GREENFIELD IN 46140
Paul Herendeen director C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Michael J Harrington director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Brabander Ellen De officer: See Remarks 2500 INNOVATION WAY, GREENFIELD IN 46140
Marcela A. Kirberger officer: Ex VP, Gen Counsel & Corp Sec C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD IN 46140
Art A Garcia director 11690 N.W. 105TH STREET, MIAMI FL 33178
William F Doyle director
Uncas Gp Llc director 250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Sachem Head Capital Management Lp director 250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Scott D. Ferguson director 250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019